Daphne Lainson

Practice Areas

Daphne Lainson has specialized in helping clients to secure patent protection for chemical, pharmaceutical and biotechnology related inventions, and advising them on regulatory law, for close to 25 years. The world’s top innovators of pharmaceuticals and biologics rely on Daphne’s strategic advice and counsel across the life cycle of a drug, including during pre-clinical and clinical development through to marketing and loss of exclusivity. What sets her apart is her deep expertise in patent procurement and the various issues that can arise relating to patent linkage under the Patented Medicines (Notice of Compliance) Regulations, supplementary protection under the Certificate of Supplementary Protection Regulations, and regulatory data exclusivity under the Food and Drug Regulations, in addition to protection under the Certificates of Supplementary Protection Regulations. She is also an expert in market access issues and pricing for patented medicines under the jurisdiction of Patented Medicine Prices Review Board (PMPRB). Daphne was named 2022 and 2024 Ottawa Lawyer of the Year for Biotechnology and Life Sciences by Best Lawyers and Canadian Patent Strategy Practitioner of the Year in 2020 and 2022 by LMG Life Sciences. She is also recognized as a leading lawyer in numerous national and international publications.